Effectiveness of Recommended Drug Classes in Secondary Prevention of Acute Coronary Syndrome in France

Julien Bezin; Rolf Groenwold; Sanni Ali; Regis Lassalle; Anthonius de Boer; Nicholas Moore; Olaf Klungel; Antoine Pariente

doi:10.1002/pds.4070

Effectiveness of Recommended Drug Classes in Secondary Prevention of Acute Coronary Syndrome in France

Julien Bezin, Rolf Groenwold, Sanni Ali, Regis Lassalle, Anthonius de Boer, Nicholas Moore, Olaf Klungel, Antoine Pariente

Research output: Contribution to journal › Meeting Abstract › Other research output

3 Downloads (Pure)

Original language	English
Article number	441
Pages (from-to)	258-259
Journal	Pharmacoepidemiology and Drug Safety
Volume	25
Issue number	Suppl. S3
DOIs	https://doi.org/10.1002/pds.4070
Publication status	Published - Aug 2016

Access to Document

10.1002/pds.4070

258Final published version, 111 KB

Cite this

@article{bc5708b818274d65ae8b9f53cf31a8cb,

title = "Effectiveness of Recommended Drug Classes in Secondary Prevention of Acute Coronary Syndrome in France",

author = "Julien Bezin and Rolf Groenwold and Sanni Ali and Regis Lassalle and \{de Boer\}, Anthonius and Nicholas Moore and Olaf Klungel and Antoine Pariente",

note = "Abstracts of the 32nd International Conference on Pharmacoepidemiology \& Therapeutic Risk Management, The Convention Centre Dublin, Dublin, Ireland August 25–28, 2016",

year = "2016",

month = aug,

doi = "10.1002/pds.4070",

language = "English",

volume = "25",

pages = "258--259",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley \& Sons Inc.",

number = "Suppl. S3",

}

TY - JOUR

T1 - Effectiveness of Recommended Drug Classes in Secondary Prevention of Acute Coronary Syndrome in France

AU - Bezin, Julien

AU - Groenwold, Rolf

AU - Ali, Sanni

AU - Lassalle, Regis

AU - de Boer, Anthonius

AU - Moore, Nicholas

AU - Klungel, Olaf

AU - Pariente, Antoine

N1 - Abstracts of the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, The Convention Centre Dublin, Dublin, Ireland August 25–28, 2016

PY - 2016/8

Y1 - 2016/8

U2 - 10.1002/pds.4070

DO - 10.1002/pds.4070

M3 - Meeting Abstract

SN - 1053-8569

VL - 25

SP - 258

EP - 259

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - Suppl. S3

M1 - 441

ER -